Trials / Completed
CompletedNCT05582304
Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This will be a split-plot design, randomized, parallel, double-masked feasibility study to evaluate the role of a test lens on contrast sensitivity with and without glare.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Test Lens | ACUVUE OASYS MAX 1-Day with TearStable Technology and OptiBlue Light Filter |
| DEVICE | Control Lens | ACUVUE OASYS 1-Day with HydraLuxe Technology |
Timeline
- Start date
- 2022-10-31
- Primary completion
- 2022-12-08
- Completion
- 2022-12-08
- First posted
- 2022-10-17
- Last updated
- 2024-01-31
- Results posted
- 2024-01-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05582304. Inclusion in this directory is not an endorsement.